Neil Nagaria, MD
Gastroenterology · Toms River, NJNPI 1760401749
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,408 of the $74,674 with a category attached, or 76.9%. Madrigal Pharmaceuticals accounts for 85.4% of it on its own, with 35 other manufacturers making up the rest. 2025 is the largest year on record at $57,443, more than ten times the $433 reported in 2019. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 697 payments — averaging $107.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$64K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$664
- Johnson & Johnson$575
- Sanofi$555
- plus $6K from 30 others
Across 78 payments — averaging $4708.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$302K
- Bausch Health US, LLC$65K
What the payments were for
- Consulting fees$9681%
- Speaking & faculty fees$57,40877%
- Travel & lodging$2,8594%
- Food & beverage$13,31818%
- Education$1220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 66 | $63,773 |
| AbbVie(2 entities) | 147 | $2,415 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 77 | $1,180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 39 | $664 |
| Johnson & Johnson | 17 | $575 |
| Sanofi | 38 | $555 |
| Gilead | 34 | $507 |
| Aimmune Therapeutics, Inc. | 26 | $506 |
| Nestle Healthcare Nutrition Inc. | 25 | $500 |
| Ardelyx, Inc. | 22 | $460 |
| Pfizer | 28 | $429 |
| Daiichi Sankyo Inc. | 29 | $413 |
| Bristol Myers Squibb | 29 | $379 |
| Lilly USA, LLC | 19 | $316 |
| Redhill Biopharma Inc. | 20 | $280 |
| Phathom Pharmaceuticals, Inc. | 5 | $258 |
| Vivus LLC | 14 | $196 |
| Merck | 12 | $178 |
| Novo Nordisk | 3 | $137 |
| Intercept Pharmaceuticals, Inc. | 8 | $120 |
| Ferring Pharmaceuticals Inc. | 7 | $114 |
| Janssen Scientific Affairs, LLC | 1 | $113 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Ipsen Biopharmaceuticals, Inc | 5 | $91 |
| Axonics, Inc. | 1 | $88 |
| Celltrion USA Inc. | 3 | $55 |
| Laborie Medical Technologies Corp. | 1 | $46 |
| Organon | 3 | $45 |
| Ironwood Pharmaceuticals, Inc | 3 | $42 |
| Intra-sana Laboratories | 2 | $33 |
| Evoke Pharma, Inc. | 2 | $30 |
| QOL Medical, LLC | 2 | $25 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $15 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$74,674 in reported general payments places this provider in the 95th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 15 | $399,456 |
| CreonLipase/Protease/Amylase | 32 | $117,402 |
| LinzessLinaclotide | 144 | $108,535 |
| XifaxanRifaximin | 25 | $72,746 |
| ZenpepLipase/Protease/Amylase | 14 | $53,760 |
| RezdiffraResmetirom | 11 | $43,503 |
| Dexlansoprazole DrDexlansoprazole | 77 | $35,969 |
| RybelsusSemaglutide | 25 | $26,470 |
| TrulancePlecanatide | 18 | $16,816 |
| OzempicSemaglutide | 15 | $14,013 |
| Pantoprazole Sodium | 924 | $12,085 |
| Mesalamine | 28 | $9,238 |
| Colesevelam Hcl | 117 | $5,986 |
| Lubiprostone | 44 | $5,685 |
| Ursodiol | 14 | $4,504 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $575 | $399,45615 claims |
| AbbVieCreon, Linzess | $2,415 | $225,936176 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance | $1,180 | $89,56143 claims |
| Aimmune Therapeutics, Inc.Zenpep | $506 | $53,76014 claims |
| Madrigal PharmaceuticalsRezdiffra | $63,773 | $43,50311 claims |
| Novo NordiskRybelsus, Ozempic | $137 | $40,48340 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $664 | $3,59212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 701 gastroenterology providers in New Jersey.
Other gastroenterology in Toms River
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
- Anish ShethPrinceton$151K
- Ramesh GuptaFair Lawn$143K
- Sanket PatelVoorhees$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.